Whether these SNPs enhance CRC risk by affecting alternative splicing of CHRDL2 mRNA or by increasing CHRDL2 expression via epigenetic or gene regulatory mechanisms is yet to be elucidated. This evidence concerns the gene CHRDL2 and colorectal carcinoma.